The BSE Sensex rose on Friday as defensive stocks such as Sun Pharmaceutical Industries and Ranbaxy Laboratories jumped on the US regulator's approval for a key drug while IT stocks gained after rival Accenture Plc reported robust quarterly revenue growth.
Ranbaxy provisionally rose 4.6% while its new owner Sun Pharma ended 3.9% higher.
Among software stocks, Tata Consultancy Services provisionally rose 4% while Infosys ended 1.4% higher.
The Sensex provisionally closed 0.15% higher, while the Nifty gained 0.24%, shrugging off two consecutive days of declines.
